{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T19:14:11Z","timestamp":1788376451849,"version":"build-2803163510"},"reference-count":55,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:00Z","timestamp":1788134400000},"content-version":"vor","delay-in-days":242,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000361","name":"Diabetes UK","doi-asserted-by":"publisher","award":["14\/0004472"],"award-info":[{"award-number":["14\/0004472"]}],"id":[{"id":"10.13039\/501100000361","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000361","name":"Diabetes UK","doi-asserted-by":"publisher","award":["14\/0004869"],"award-info":[{"award-number":["14\/0004869"]}],"id":[{"id":"10.13039\/501100000361","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000361","name":"Diabetes UK","doi-asserted-by":"publisher","award":["18\/0005778"],"award-info":[{"award-number":["18\/0005778"]}],"id":[{"id":"10.13039\/501100000361","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000361","name":"Diabetes UK","doi-asserted-by":"publisher","award":["3-APF-2018-591-A-N"],"award-info":[{"award-number":["3-APF-2018-591-A-N"]}],"id":[{"id":"10.13039\/501100000361","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000361","name":"Diabetes UK","doi-asserted-by":"publisher","award":["16\/0005556"],"award-info":[{"award-number":["16\/0005556"]}],"id":[{"id":"10.13039\/501100000361","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000361","name":"Diabetes UK","doi-asserted-by":"publisher","award":["18\/0005778"],"award-info":[{"award-number":["18\/0005778"]}],"id":[{"id":"10.13039\/501100000361","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000361","name":"Diabetes UK","doi-asserted-by":"publisher","award":["21\/0006332"],"award-info":[{"award-number":["21\/0006332"]}],"id":[{"id":"10.13039\/501100000361","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Autoantibodies to zinc transporter 8 (ZnT8A) are important diagnostic and predictive markers for type 1 diabetes (T1D). Current methods to detect ZnT8A use C-terminal ZnT8 (aa268-369). Previous research identified three major ZnT8A epitopes (R325, W325, and a four-residue conformational epitope [R332\/E333\/K336\/K340]), but the human-specific cysteine region has not been investigated. We sought to examine ZnT8A binding to three C-terminal cysteines and confirm previously known ZnT8A epitopes. Assay buffer constituent (Tween-20) and site-directed mutagenesis of radiolabelled ZnT8 antigen were utilized to compare ZnT8A binding in R325-ZnT8 and W325-ZnT8 monomeric radiobinding assays (RBAs). Truncated ZnT8 (D360X) and cysteine-to-serine mutations (C361S, C364S, and C368S) were compared with wild-type R325-ZnT8\/W325-ZnT8 RBAs in 71 newly diagnosed T1D cases. Samples were indexed to controls and the median reduction in binding (MRB, %) was compared using Wilcoxon signed-ranked tests. Unbiased hierarchical clustering analysis was used to review effects of all ZnT8 mutations. A higher Tween-20 concentration reduced ZnT8A binding (P &amp;lt; 0.0001). All cysteine region mutations reduced 325-agnostic ZnT8A binding towards wild-type R325-ZnT8 (MRB range \u221237.0 to \u221266.4%, P &amp;lt; 0.0001) and W325-ZnT8 (MRB range \u221232.1 to \u221243.8%, P &amp;lt; 0.0001). Mutating the cysteine region nearly abolished binding (&amp;gt;75%) in 7.7\u201336.8% of R325-ZnT8\/W325-ZnT8 positive ZnT8A, and in 10.5\u201313.2% of subjects studied, reduced binding below that of major ZnT8A epitopes. The cysteine region of C-terminal ZnT8 constitutes an independent epitope for ZnT8A, but mature ZnT8A responses in newly diagnosed T1D are heterogeneous. Epitope spreading of ZnT8A during the natural history of preclinical T1D remains unclear and requires further investigation in larger studies.<\/jats:p>","DOI":"10.1093\/cei\/uxag050","type":"journal-article","created":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T11:46:53Z","timestamp":1787140013000},"source":"Crossref","is-referenced-by-count":0,"title":["The C-terminal cysteines in zinc transporter 8 (ZnT8) form an independent epitope for autoantibody binding in newly diagnosed type 1 diabetes"],"prefix":"10.1093","volume":"220","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6641-8018","authenticated-orcid":false,"given":"Claire L","family":"Williams","sequence":"first","affiliation":[{"name":"Bristol Medical School, University of Bristol, Level 2, Learning and Research Building, Southmead Hospital , Bristol ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Rokni","sequence":"additional","affiliation":[{"name":"Bristol Medical School, University of Bristol, Level 2, Learning and Research Building, Southmead Hospital , Bristol ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5162-8445","authenticated-orcid":false,"given":"V","family":"Lampasona","sequence":"additional","affiliation":[{"name":"San Raffaele Diabetes Research Institute, IRCCS San Raffaele Scientific Institute , Milan ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2914-1654","authenticated-orcid":false,"given":"C","family":"Brigatti","sequence":"additional","affiliation":[{"name":"San Raffaele Diabetes Research Institute, IRCCS San Raffaele Scientific Institute , Milan ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0277-1744","authenticated-orcid":false,"given":"B T","family":"Gillard","sequence":"additional","affiliation":[{"name":"Bristol Medical School, University of Bristol, Level 2, Learning and Research Building, Southmead Hospital , Bristol ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3009-8032","authenticated-orcid":false,"given":"K M","family":"Gillespie","sequence":"additional","affiliation":[{"name":"Bristol Medical School, University of Bristol, Level 2, Learning and Research Building, Southmead Hospital , Bristol ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A J K","family":"Williams","sequence":"additional","affiliation":[{"name":"Bristol Medical School, University of Bristol, Level 2, Learning and Research Building, Southmead Hospital , Bristol ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6847-2771","authenticated-orcid":false,"given":"A E","family":"Long","sequence":"additional","affiliation":[{"name":"Bristol Medical School, University of Bristol, Level 2, Learning and Research Building, Southmead Hospital , Bristol ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,8,31]]},"reference":[{"key":"2026090214271808500_uxag050-B1","doi-asserted-by":"crossref","first-page":"17040","DOI":"10.1073\/pnas.0705894104","article-title":"The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes","volume":"104","author":"Wenzlau","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026090214271808500_uxag050-B2","doi-asserted-by":"crossref","first-page":"4199","DOI":"10.1242\/jcs.03164","article-title":"In vivo expression and functional characterization of the zinc transporter ZnT8 in glucose-induced insulin secretion","volume":"119","author":"Chimienti","year":"2006","journal-title":"J Cell Sci"},{"key":"2026090214271808500_uxag050-B3","doi-asserted-by":"crossref","DOI":"10.1111\/dme.14979","article-title":"The measurement of autoantibodies to insulin informs diagnosis of diabetes in a childhood population negative for other autoantibodies","volume":"39","author":"Williams","year":"2022","journal-title":"Diabet Med"},{"key":"2026090214271808500_uxag050-B4","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.2337\/diab.46.11.1701","article-title":"Prediction of IDDM in the general population: strategies based on combinations of autoantibody markers","volume":"46","author":"Bingley","year":"1997","journal-title":"Diabetes"},{"key":"2026090214271808500_uxag050-B5","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s11892-016-0738-2","article-title":"Islet autoantibodies","volume":"16","author":"Lampasona","year":"2016","journal-title":"Curr Diab Rep"},{"key":"2026090214271808500_uxag050-B6","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.diabres.2010.11.012","article-title":"Association between rs13266634 C\/T polymorphisms of solute carrier family 30 member 8 (SLC30A8) and type 2 diabetes, impaired glucose tolerance, type 1 diabetes\u2013a meta-analysis","volume":"91","author":"Xu","year":"2011","journal-title":"Diabetes Res Clin Pract"},{"key":"2026090214271808500_uxag050-B7","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1007\/s11892-013-0405-9","article-title":"Novel diabetes autoantibodies and prediction of type 1 diabetes","volume":"13","author":"Wenzlau","year":"2013","journal-title":"Curr Diab Rep"},{"key":"2026090214271808500_uxag050-B8","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jtemb.2017.06.001","article-title":"Differential cytolocation and functional assays of the two major human SLC30A8 (ZnT8) isoforms","volume":"44","author":"Carvalho","year":"2017","journal-title":"J Trace Elem Med Biol"},{"key":"2026090214271808500_uxag050-B9","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.2337\/db08-0522","article-title":"A common nonsynonymous single nucleotide polymorphism in the SLC30A8 gene determines ZnT8 autoantibody specificity in type 1 diabetes","volume":"57","author":"Wenzlau","year":"2008","journal-title":"Diabetes"},{"key":"2026090214271808500_uxag050-B10","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1002\/dmrr.1266","article-title":"Mapping of conformational autoantibody epitopes in ZNT8","volume":"27","author":"Wenzlau","year":"2011","journal-title":"Diabetes Metab Res Rev"},{"key":"2026090214271808500_uxag050-B11","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/nature05616","article-title":"A genome-wide association study identifies novel risk loci for type 2 diabetes","volume":"445","author":"Sladek","year":"2007","journal-title":"Nature"},{"key":"2026090214271808500_uxag050-B12","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s11892-009-0019-4","article-title":"Novel antigens in type 1 diabetes: the importance of ZnT8","volume":"9","author":"Wenzlau","year":"2009","journal-title":"Curr Diab Rep"},{"key":"2026090214271808500_uxag050-B13","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/sji.12008","article-title":"Antigenicity and epitope specificity of ZnT8 autoantibodies in type 1 diabetes","volume":"77","author":"Skarstrand","year":"2013","journal-title":"Scand J Immunol"},{"key":"2026090214271808500_uxag050-B14","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/cei.12448","article-title":"Zinc transporter 8 (ZnT8) autoantibody epitope specificity and affinity examined with recombinant ZnT8 variant proteins in specific ZnT8R and ZnT8W autoantibody-positive type 1 diabetes patients","volume":"179","author":"Skarstrand","year":"2015","journal-title":"Clin Exp Immunol"},{"key":"2026090214271808500_uxag050-B15","doi-asserted-by":"crossref","first-page":"214","DOI":"10.2337\/db11-1590","article-title":"The core cysteines, (C909) of islet antigen-2 and (C945) of islet antigen-2beta, are crucial to autoantibody binding in type 1 diabetes","volume":"62","author":"Elvers","year":"2013","journal-title":"Diabetes"},{"key":"2026090214271808500_uxag050-B16","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jim.2009.10.004","article-title":"Azide and Tween-20 reduce binding to autoantibody epitopes of islet antigen-2; implications for assay performance and reproducibility","volume":"351","author":"Williams","year":"2009","journal-title":"J Immunol Methods"},{"key":"2026090214271808500_uxag050-B17","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.2337\/diabetes.52.5.1128","article-title":"Diabetes Antibody Standardization Program: first assay proficiency evaluation","volume":"52","author":"Bingley","year":"2003","journal-title":"Diabetes"},{"key":"2026090214271808500_uxag050-B18","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1373\/clinchem.2011.170662","article-title":"Diabetes antibody standardization program: first proficiency evaluation of assays for autoantibodies to zinc transporter 8","volume":"57","author":"Lampasona","year":"2011","journal-title":"Clin Chem"},{"key":"2026090214271808500_uxag050-B19","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1111\/febs.14402","article-title":"The C-terminal cytosolic domain of the human zinc transporter ZnT8 and its diabetes risk variant","volume":"285","author":"Parsons","year":"2018","journal-title":"FEBS J"},{"key":"2026090214271808500_uxag050-B20","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.58823","article-title":"Cryo-EM structures of human ZnT8 in both outward- and inward-facing conformations","volume":"9","author":"Xue","year":"2020","journal-title":"Elife"},{"key":"2026090214271808500_uxag050-B21","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.3390\/ijms22062940","article-title":"Probing the structure and function of the cytosolic domain of the human zinc transporter ZnT8 with Nickel(II) ions","volume":"22","author":"Catapano","year":"2021","journal-title":"Int J Mol Sci"},{"key":"2026090214271808500_uxag050-B22","doi-asserted-by":"crossref","DOI":"10.1111\/dme.14717","article-title":"Four decades of the Bart\u2019s Oxford study: improved tests to predict type 1 diabetes","volume":"38","author":"Gillespie","year":"2021","journal-title":"Diabet Med"},{"key":"2026090214271808500_uxag050-B23","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1034\/j.1399-0039.2000.560607.x","article-title":"HLA class II typing of whole genome amplified mouth swab DNA","volume":"56","author":"Gillespie","year":"2000","journal-title":"Tissue Antigens"},{"key":"2026090214271808500_uxag050-B24","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1046\/j.1525-1381.1999.09114.x","article-title":"Insulin autoantibodies and insulin antibodies have similar binding characteristics","volume":"111","author":"Brooks-Worrell","year":"1999","journal-title":"Proc Assoc Am Physicians"},{"key":"2026090214271808500_uxag050-B25","doi-asserted-by":"crossref","first-page":"683","DOI":"10.2337\/db11-0962","article-title":"Rising incidence of type 1 diabetes is associated with altered immunophenotype at diagnosis","volume":"61","author":"Long","year":"2012","journal-title":"Diabetes"},{"key":"2026090214271808500_uxag050-B26","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2337\/diacare.16.1.45","article-title":"Can islet cell antibodies predict IDDM in the general population?","volume":"16","author":"Bingley","year":"1993","journal-title":"Diabetes Care"},{"key":"2026090214271808500_uxag050-B27","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1002\/imt2.43","article-title":"Complex heatmap visualization","volume":"1","author":"Gu","year":"2022","journal-title":"Imeta"},{"key":"2026090214271808500_uxag050-B28","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1093\/bioinformatics\/btu393","article-title":"Circlize implements and enhances circular visualization in R","volume":"30","author":"Gu","year":"2014","journal-title":"Bioinformatics"},{"key":"2026090214271808500_uxag050-B29","unstructured":"Garnier S, Ross N, Rudis B, Filipovic-Pierucci A, Galili T; timelyportfolio, et al \u00a0sjmgarnier\/viridis: CRAN release v0.6.3 (v0.6.3CRAN). Zenodo2023. 10.5281\/zenodo.7890878."},{"key":"2026090214271808500_uxag050-B30","author":"Team RC"},{"key":"2026090214271808500_uxag050-B31","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1007\/s00125-005-1719-1","article-title":"Dynamic changes of GAD65 autoantibody epitope specificities in individuals at risk of developing type 1 diabetes","volume":"48","author":"Schlosser","year":"2005","journal-title":"Diabetologia"},{"key":"2026090214271808500_uxag050-B32","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/j.1365-2249.2005.02802.x","article-title":"Epitope analysis of insulin autoantibodies using recombinant Fab","volume":"140","author":"Padoa","year":"2005","journal-title":"Clin Exp Immunol"},{"key":"2026090214271808500_uxag050-B33","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.4049\/jimmunol.157.6.2707","article-title":"Autoantibodies in insulin-dependent diabetes recognize distinct cytoplasmic domains of the protein tyrosine phosphatase-like IA-2 autoantigen","volume":"157","author":"Lampasona","year":"1996","journal-title":"J Immunol"},{"key":"2026090214271808500_uxag050-B34","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1126\/science.1143748","article-title":"Structure of the zinc transporter YiiP","volume":"317","author":"Lu","year":"2007","journal-title":"Science"},{"key":"2026090214271808500_uxag050-B35","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1038\/nsmb.1662","article-title":"Structural basis for autoregulation of the zinc transporter YiiP","volume":"16","author":"Lu","year":"2009","journal-title":"Nat Struct Mol Biol"},{"key":"2026090214271808500_uxag050-B36","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1758-5996-2-33","article-title":"Three-dimensional structure of beta-cell-specific zinc transporter, ZnT-8, predicted from the type 2 diabetes-associated gene variant SLC30A8 R325W","volume":"2","author":"Weijers","year":"2010","journal-title":"Diabetol Metab Syndr"},{"key":"2026090214271808500_uxag050-B37","doi-asserted-by":"crossref","first-page":"10196","DOI":"10.1073\/pnas.1711169114","article-title":"Proteoliposome-based full-length ZnT8 self-antigen for type 1 diabetes diagnosis on a plasmonic platform","volume":"114","author":"Wan","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026090214271808500_uxag050-B38","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41586-024-07487-w","article-title":"Accurate structure prediction of biomolecular interactions with AlphaFold 3","volume":"630","author":"Abramson","year":"2024","journal-title":"Nature"},{"key":"2026090214271808500_uxag050-B39","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1002\/prot.20264","article-title":"Scoring function for automated assessment of protein structure template quality","volume":"57","author":"Zhang","year":"2004","journal-title":"Proteins"},{"key":"2026090214271808500_uxag050-B40","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1093\/bioinformatics\/btq066","article-title":"How significant is a protein structure similarity with TM-score = 0.5?","volume":"26","author":"Xu","year":"2010","journal-title":"Bioinformatics"},{"key":"2026090214271808500_uxag050-B41","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1210\/jc.2010-0293","article-title":"Harmonization of glutamic acid decarboxylase and islet antigen-2 autoantibody assays for national institute of diabetes and digestive and kidney diseases consortia","volume":"95","author":"Bonifacio","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"2026090214271808500_uxag050-B42","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1006\/jaut.1997.0154","article-title":"A novel micro-assay for insulin autoantibodies","volume":"10","author":"Williams","year":"1997","journal-title":"J Autoimmun"},{"key":"2026090214271808500_uxag050-B43","first-page":"3455","article-title":"High-affinity ZnT8 autoantibodies by electrochemiluminescence assay improve risk prediction for type 1 diabetes","volume":"106","author":"Jia","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"2026090214271808500_uxag050-B44","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s00592-013-0532-4","article-title":"Novel enzyme-linked immunosorbent assay for bivalent ZnT8 autoantibodies","volume":"51","author":"Kawasaki","year":"2014","journal-title":"Acta Diabetol"},{"key":"2026090214271808500_uxag050-B45","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.cca.2015.05.010","article-title":"Bridging-type enzyme-linked immunoassay for zinc transporter 8 autoantibody measurements in adult patients with diabetes mellitus","volume":"447","author":"Dunseath","year":"2015","journal-title":"Clin Chim Acta"},{"key":"2026090214271808500_uxag050-B46","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/cei\/uxad139","article-title":"A novel, high-performance, low-volume, rapid luciferase immunoprecipitation system (LIPS) assay to detect autoantibodies to zinc transporter 8","volume":"215","author":"Williams","year":"2024","journal-title":"Clin Exp Immunol"},{"key":"2026090214271808500_uxag050-B47","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.cca.2016.08.013","article-title":"3 screen islet cell autoantibody ELISA: a sensitive and specific ELISA for the combined measurement of autoantibodies to GAD(65), to IA-2 and to ZnT8","volume":"462","author":"Amoroso","year":"2016","journal-title":"Clin Chim Acta"},{"key":"2026090214271808500_uxag050-B48","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1089\/dia.2021.0517","article-title":"High-throughput multiplex electrochemiluminescence assay applicable to general population screening for type 1 diabetes and celiac disease","volume":"24","author":"He","year":"2022","journal-title":"Diabetes Technol Ther"},{"key":"2026090214271808500_uxag050-B49","doi-asserted-by":"crossref","DOI":"10.1016\/j.jim.2022.113265","article-title":"Multiplex agglutination-PCR (ADAP) autoantibody assays compared to radiobinding autoantibodies in type 1 diabetes and celiac disease","volume":"506","author":"Lind","year":"2022","journal-title":"J Immunol Methods"},{"key":"2026090214271808500_uxag050-B50","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1007\/s00125-012-2472-x","article-title":"Age-related islet autoantibody incidence in offspring of patients with type 1 diabetes","volume":"55","author":"Ziegler","year":"2012","journal-title":"Diabetologia"},{"key":"2026090214271808500_uxag050-B51","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2021.102677","article-title":"Novel autoantibodies to the beta-cell surface epitopes of ZnT8 in patients progressing to type-1 diabetes","volume":"122","author":"Gu","year":"2021","journal-title":"J Autoimmun"},{"key":"2026090214271808500_uxag050-B52","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1074\/jbc.RA117.000195","article-title":"A subclass of serum anti-ZnT8 antibodies directed to the surface of live pancreatic beta-cells","volume":"293","author":"Merriman","year":"2018","journal-title":"J Biol Chem"},{"key":"2026090214271808500_uxag050-B53","first-page":"1276","article-title":"Consensus guidance for monitoring individuals with islet autoantibody-positive pre-stage 3 type 1 diabetes","volume":"47","author":"Phillip","year":"2024","journal-title":"Diabetes Care"},{"key":"2026090214271808500_uxag050-B54","doi-asserted-by":"crossref","first-page":"607","DOI":"10.2337\/dc25-1326","article-title":"Interlaboratory evaluation of multiplex autoantibody assay performance in the islet autoantibody standardization program 2024 workshop","volume":"49","author":"Marzinotto","year":"2026","journal-title":"Diabetes Care"},{"key":"2026090214271808500_uxag050-B55","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s00125-025-06591-4","article-title":"Evolution of islet autoantibodies in the Environmental Determinants of Islet Autoimmunity (ENDIA) prospective cohort","volume":"69","author":"Couper","year":"2026","journal-title":"Diabetologia"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cei\/advance-article-pdf\/doi\/10.1093\/cei\/uxag050\/70878866\/uxag050.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/220\/1\/uxag050\/70878866\/uxag050.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/220\/1\/uxag050\/70878866\/uxag050.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T18:27:28Z","timestamp":1788373648000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/doi\/10.1093\/cei\/uxag050\/8776361"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,6]]}},"URL":"https:\/\/doi.org\/10.1093\/cei\/uxag050","relation":{},"ISSN":["0009-9104","1365-2249"],"issn-type":[{"value":"0009-9104","type":"print"},{"value":"1365-2249","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026]]},"published":{"date-parts":[[2026]]},"article-number":"uxag050"}}